Page last updated: 2024-08-22

ornithylaspartate and Hyperammonemia

ornithylaspartate has been researched along with Hyperammonemia in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (38.46)29.6817
2010's7 (53.85)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Fan, Y; Jiang, H; Li, M; Shao, J; Zhang, M1
Butterworth, RF2
Bogomolov, PO; Buyeverov, AO; Matsievich, MV; Mayev, IV; Uvarova, OV1
Ahn, JO; Chung, JY; Han, SM; Hwang, CY; Lee, YH; Li, Q; Youn, HY1
Achermann, P; Amodio, P; Angeli, P; Garrido, M; Montagnese, S; Raduazzo, D; Skorucak, J; Spinelli, G; Turco, M1
Ahmad, I; Alam, A; Butt, AK; Dilshad, A; Khan, AA; Malik, K; Sarwar, S; Shafqat, F1
Jalan, R; Lee, WM1
Acharya, SK; Bhatia, V; Khanal, S; Panda, SK; Sreenivas, V1
Jalan, R; Noiret, L; Olde Damink, SW; Wright, G1
Blanco Vela, CI; Poo Ramírez, JL1
Bautista, JD; Grande, L; Ramos Guerrero, RM; Romero Gómez, M; Sánchez Muñoz, D1

Reviews

3 review(s) available for ornithylaspartate and Hyperammonemia

ArticleYear
L-Ornithine L-Aspartate for the Treatment of Sarcopenia in Chronic Liver Disease: The Taming of a Vicious Cycle.
    Canadian journal of gastroenterology & hepatology, 2019, Volume: 2019

    Topics: Ammonia; Dipeptides; End Stage Liver Disease; Humans; Hyperammonemia; Liver; Sarcopenia; Treatment Outcome

2019
Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:2

    Topics: Adipose Tissue; Amino Acids; Ammonia; Arginine; Brain; Dipeptides; Glutamate-Ammonia Ligase; Glutaminase; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Mucosa; Kidney; Liver; Liver Failure; Lung; Muscles; Phenylbutyrates; Sodium Benzoate

2011
[New concepts in the physiopathology of hepatic encephalopathy and therapeutic prospects].
    Gastroenterologia y hepatologia, 2004, Volume: 27 Suppl 1

    Topics: Ammonia; Brain; Brain Edema; Dipeptides; Flumazenil; Glutaminase; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Inflammation; Intestine, Small; Kidney; Memantine; Models, Molecular; Nerve Tissue Proteins; Nitric Oxide

2004

Trials

2 trial(s) available for ornithylaspartate and Hyperammonemia

ArticleYear
L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2008, Volume: 18, Issue:11

    Topics: Adult; Aged; Ammonia; Cognition; Dipeptides; Female; Health Status Indicators; Hepatic Encephalopathy; Humans; Hyperammonemia; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Postprandial Period

2008
Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study.
    Gastroenterology, 2009, Volume: 136, Issue:7

    Topics: Adult; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hyperammonemia; Kaplan-Meier Estimate; Liver Failure, Acute; Male; Probability; Prospective Studies; Reference Values; Risk Assessment; Statistics, Nonparametric; Survival Analysis; Treatment Outcome

2009

Other Studies

8 other study(ies) available for ornithylaspartate and Hyperammonemia

ArticleYear
Establishment of hyperammonemia mode in yellow catfish and the mitigation of exogenous L-ornithine-L-aspartate.
    Developmental and comparative immunology, 2022, Volume: 135

    Topics: Ammonia; Animals; Catfishes; Dipeptides; Hyperammonemia; Sodium Chloride

2022
L-Ornithine L-Aspartate (LOLA) for the Treatment of Hepatic Encephalopathy in Cirrhosis: Novel Insights and Translation to the Clinic.
    Drugs, 2019, Volume: 79, Issue:Suppl 1

    Topics: Astrocytes; Dipeptides; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Translational Research, Biomedical

2019
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage.
    Terapevticheskii arkhiv, 2019, Mar-18, Volume: 91, Issue:2

    Topics: Adult; Ammonia; Case-Control Studies; Dipeptides; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Hyperammonemia; Male; Treatment Outcome

2019
Hyperammonemic hepatic encephalopathy management through L-ornithin-L-aspartate administration in dogs.
    Journal of veterinary science, 2016, Sep-30, Volume: 17, Issue:3

    Topics: Ammonia; Animals; Dipeptides; Dog Diseases; Dogs; Female; Hepatic Encephalopathy; Hyperammonemia; Male

2016
Vigilance and wake EEG architecture in simulated hyperammonaemia: a pilot study on the effects of L-Ornithine-L-Aspartate (LOLA) and caffeine.
    Metabolic brain disease, 2016, Volume: 31, Issue:4

    Topics: Adult; Brain; Caffeine; Dipeptides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Wakefulness

2016
Treatment of hyperammonemia in liver failure: a tale of two enzymes.
    Gastroenterology, 2009, Volume: 136, Issue:7

    Topics: Dipeptides; Double-Blind Method; Female; Humans; Hyperammonemia; Liver Failure, Acute; Male; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Survival Rate; Treatment Outcome

2009
Efficacy of oral L-ornithine L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy.
    Annals of hepatology, 2011, Volume: 10 Suppl 2

    Topics: Administration, Oral; Ammonia; Dipeptides; Glutamine; Hepatic Encephalopathy; Humans; Hyperammonemia; Liver Cirrhosis; Quality of Life; Severity of Illness Index; Treatment Outcome; Urea

2011
[In liver cirrhosis, not every "ammonia lowering drug" improves neuropsychiatric deficit].
    MMW Fortschritte der Medizin, 2001, Mar-01, Volume: 143, Issue:9

    Topics: Clinical Trials as Topic; Dipeptides; Hepatic Encephalopathy; Hyperammonemia; Neuropsychological Tests; Treatment Outcome

2001